Junshi Biosciences Announces Toripalimab’s NDA Accepted by the Singapore Health Sciences Authority

Junshi Biosciences Announces Toripalimab’s NDA Accepted by the Singapore Health Sciences Authority
SHANGHAI, China, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading...
SHANGHAI, China, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovatio... Read More



Related Stories

See All